Unit of Vascular Surgery, Department of Surgery "Pietro Valdoni", Sapienza University of Rome, Rome, Italy.
Clinica Mater Dei Hospital, Rome, Italy.
J Vasc Surg. 2019 Sep;70(3):672-682.e1. doi: 10.1016/j.jvs.2018.11.046. Epub 2019 Mar 11.
The objective of this study was to assess early and midterm results after endovascular aortic arch repair using a double inner branch stent graft (DIBSG) in patients with aortic arch aneurysm or dissection unfit for open surgery.
Between 2012 and 2018, there were 24 patients with aortic arch disease who were treated with a single model of a DIBSG (Terumo Aortic, Glasgow, United Kingdom) in nine Italian cardiovascular centers. We investigated technical success, mortality, occurrence of major complications, and need for reintervention in a multicenter, nonrandomized, retrospective fashion.
The in-hospital mortality rate was 16.7%. Cerebrovascular events occurred in 25% of patients and major strokes in 12.5%. Two patients experienced a retrograde dissection (8.3%), whereas none reported any type I or type III endoleak. During a mean follow-up of 18 months (range, 1-60 months), one patient died of a nonaortic cause and one reported a nonarch-related major stroke. No late secondary intervention was needed during the follow-up. Excluding from the analysis the first six patients treated until 2014 as part of the learning curve, in-hospital mortality, major stroke, and retrograde dissection rates were 11.1%, 11.1%, and 5.6%, respectively.
Endovascular aortic arch repair using this model of DIBSG is feasible, and results are acceptable for a new technique in a high-risk subset of patients. Operative mortality suffers the effect of a learning curve, whereas midterm aorta-related survival is promising. Endovascular repair of aortic arch disease with a DIBSG should always be considered to give high-risk patients a chance of repair. Large-scale studies are needed to assess the long-term durability of this technique.
本研究旨在评估使用双内分支支架移植物(DIBSG)对不适合开放手术的主动脉弓动脉瘤或夹层患者进行血管内主动脉弓修复的早期和中期结果。
2012 年至 2018 年,9 家意大利心血管中心的 24 例主动脉弓疾病患者使用单一型号的 DIBSG(Terumo Aortic,Glasgow,英国)进行治疗。我们以多中心、非随机、回顾性的方式调查了技术成功率、死亡率、主要并发症的发生情况和再次干预的需求。
住院死亡率为 16.7%。25%的患者发生脑血管事件,12.5%发生重大中风。2 例患者发生逆行夹层(8.3%),无一例报告任何类型 I 或类型 III 内漏。在平均 18 个月(1-60 个月)的随访期间,1 例患者因非主动脉原因死亡,1 例报告非弓相关的主要中风。在随访期间无需进行晚期二次干预。排除 2014 年前作为学习曲线一部分治疗的前 6 例患者,住院死亡率、主要中风和逆行夹层发生率分别为 11.1%、11.1%和 5.6%。
使用这种 DIBSG 模型进行血管内主动脉弓修复是可行的,对于高危患者的新技术来说,结果是可以接受的。手术死亡率受到学习曲线的影响,而中期与主动脉相关的生存率是有希望的。对于高危患者,应始终考虑使用 DIBSG 进行主动脉弓疾病的血管内修复,以给予他们修复的机会。需要进行大规模研究来评估该技术的长期耐久性。